We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$919M
AUM Growth
+$100M
Cap. Flow
+$8.56M
Cap. Flow %
0.93%
Top 10 Hldgs %
73.95%
Holding
3,000
New
528
Increased
1,514
Reduced
448
Closed
116
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCAL
2051
T. Rowe Price Capital Appreciation Premium Income ETF
TCAL
$286M
$939 ﹤0.01%
42
AVBP icon
2052
ArriVent BioPharma
AVBP
$1.4B
$938 ﹤0.01%
+27
New +$797
EOSE icon
2053
Eos Energy Enterprises
EOSE
$1.14B
$936 ﹤0.01%
159
-11
-6% -$76
ALRM icon
2054
Alarm.com
ALRM
$2.75B
$935 ﹤0.01%
20
+11
+122% +$493
BKKT icon
2055
Bakkt Inc
BKKT
$306M
$930 ﹤0.01%
119
+114
+2,280% +$1.02K
ACH
2056
Accendra Health
ACH
$254M
$927 ﹤0.01%
271
+266
+5,320% +$827
AURA icon
2057
Aura Biosciences
AURA
$725M
$923 ﹤0.01%
130
+128
+6,400% +$916
GENI icon
2058
Genius Sports
GENI
$1.95B
$922 ﹤0.01%
+152
New +$787
ASR icon
2059
Grupo Aeroportuario del Sureste
ASR
$8.16B
$921 ﹤0.01%
3
ACCO icon
2060
Acco Brands
ACCO
$399M
$920 ﹤0.01%
221
+199
+905% +$731
TECH icon
2061
Bio-Techne
TECH
$11.2B
$919 ﹤0.01%
13
-329
-96% -$17.8K
VSXY
2062
Victoria's Secret
VSXY
$7.09B
$919 ﹤0.01%
11
LILA icon
2063
Liberty Latin America Class A
LILA
$1.72B
$918 ﹤0.01%
+117
New +$652
QQQJ icon
2064
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.11B
$911 ﹤0.01%
20
ARCC icon
2065
Ares Capital
ARCC
$13.4B
$900 ﹤0.01%
49
-1,498
-97% -$28K
AVPT icon
2066
AvePoint
AVPT
$2.76B
$897 ﹤0.01%
80
+46
+135% +$473
MXL icon
2067
MaxLinear
MXL
$5.19B
$897 ﹤0.01%
7
+2
+40% +$141
PLSE icon
2068
Pulse Biosciences
PLSE
$2.37B
$888 ﹤0.01%
+32
New +$755
CTEV
2069
Claritev Corp
CTEV
$399M
$887 ﹤0.01%
26
+25
+2,500% +$612
UAA icon
2070
Under Armour
UAA
$3.01B
$882 ﹤0.01%
138
+88
+176% +$522
MAGN
2071
Magnera Corp
MAGN
$493M
$882 ﹤0.01%
75
+71
+1,775% +$778
CHCT
2072
Community Healthcare Trust
CHCT
$536M
$878 ﹤0.01%
48
+23
+92% +$399
CTMX icon
2073
CytomX Therapeutics
CTMX
$690M
$870 ﹤0.01%
+232
New +$886
SYNA icon
2074
Synaptics
SYNA
$4.05B
$870 ﹤0.01%
7
VCSH icon
2075
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$870 ﹤0.01%
11

Similar funds

SJS Investment Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, SJS Investment Consulting held 3,000 positions worth $919M, up 12% from $819M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

SJS Investment Consulting's Q2 2026 filing shows 528 new, 1,514 increased, 448 reduced and 116 closed positions. Its largest new stake was Kestra Medical Technologies: 20,060 shares worth $510K. The largest sale was Dimensional Short-Duration Fixed Income ETF, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5% a quarter earlier, followed by Healthcare and Consumer Staples.

  • SJS Investment Consulting's largest Q2 2026 buy was Kestra Medical Technologies: 20,060 shares worth $510K.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q2 2026, an estimated $6.25M increase.
  • SJS Investment Consulting's biggest Q2 2026 reduction was Dimensional Short-Duration Fixed Income ETF, cutting an estimated $17.6M.
  • SJS Investment Consulting fully exited Vanguard Short Duration Bond ETF in Q2 2026, selling an estimated $299K.
  • SJS Investment Consulting's ten largest holdings make up 74% of its $919M portfolio in Q2 2026.
  • SJS Investment Consulting opened 528 new positions and closed 116 in Q2 2026.
  • SJS Investment Consulting's portfolio value rose 12% quarter-over-quarter to $919M.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.